Business Description
Medeze Group PCL
SIC : 2836
ISIN : THC430010007
Description
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment. Geographically, the company operates in Thailand, Vietnam, Cambodia, Philippines, and Other countries, of which maximum revenue is derived from Thailand.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 97.25 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.08 | |||||
Interest Coverage | 7.86 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 8.53 | |||||
Beneish M-Score | -2.55 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 29.29 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 18.78 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 8.72 | |||||
9-Day RSI | 21.88 | |||||
14-Day RSI | 31.39 | |||||
3-1 Month Momentum % | 6.56 | |||||
6-1 Month Momentum % | 4.84 | |||||
12-1 Month Momentum % | -8.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 16.88 | |||||
Quick Ratio | 16.54 | |||||
Cash Ratio | 15.48 | |||||
Days Inventory | 71.31 | |||||
Days Sales Outstanding | 37.61 | |||||
Days Payable | 12.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.54 | |||||
Dividend Payout Ratio | 1 | |||||
Forward Dividend Yield % | 3.81 | |||||
5-Year Yield-on-Cost % | 2.5 | |||||
Shareholder Yield % | 2.58 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.24 | |||||
Operating Margin % | 26.82 | |||||
Net Margin % | 21.19 | |||||
EBITDA Margin % | 31.51 | |||||
FCF Margin % | 10.43 | |||||
OCF Margin % | 23.88 | |||||
ROE % | 4.79 | |||||
ROA % | 4.04 | |||||
ROIC % | 10.33 | |||||
ROC (Joel Greenblatt) % | 25.76 | |||||
ROCE % | 4.91 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 47.69 | |||||
Forward PE Ratio | 22.14 | |||||
PE Ratio without NRI | 38.75 | |||||
PS Ratio | 9.92 | |||||
PB Ratio | 2.24 | |||||
Price-to-Tangible-Book | 2.25 | |||||
Price-to-Free-Cash-Flow | 310 | |||||
Price-to-Operating-Cash-Flow | 42.47 | |||||
EV-to-EBIT | 30.6 | |||||
EV-to-Forward-EBIT | 18.08 | |||||
EV-to-EBITDA | 24.16 | |||||
EV-to-Forward-EBITDA | 15.42 | |||||
EV-to-Revenue | 7.61 | |||||
EV-to-Forward-Revenue | 5.6 | |||||
EV-to-FCF | 214.91 | |||||
Price-to-Graham-Number | 1.97 | |||||
| Price-to-Net-Current-Asset-Value | 5.74 | |||||
| Price-to-Net-Cash | 6.53 | |||||
Earnings Yield (Greenblatt) % | 3.27 | |||||
FCF Yield % | 0.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medeze Group PCL Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 667.784 | ||
| EPS (TTM) (฿) | 0.133 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 16.41 | ||
| 14-Day RSI | 31.39 | ||
| 14-Day ATR (฿) | 0.118378 | ||
| 20-Day SMA (฿) | 6.44 | ||
| 12-1 Month Momentum % | -8.45 | ||
| 52-Week Range (฿) | 6 - 7.45 | ||
| Shares Outstanding (Mil) | 1,068 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medeze Group PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medeze Group PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| THB 0.080000 Cash Dividend | 2026-04-29 | 6.15 (-0.81%) | ||
| THB 0.080000 Cash Dividend | 2025-11-21 | 6.35 (+0.79%) | ||
| THB 0.080000 Cash Dividend | 2025-05-06 | 7.25 (+0.00%) | ||
| THB 0.080000 Cash Dividend | 2024-11-26 | 7.75 (-3.73%) |
Show
Entries
Medeze Group PCL Frequently Asked Questions
What is Medeze Group PCL(BKK:MEDEZE)'s stock price today?
The current price of BKK:MEDEZE is ฿6.20. The 52 week high of BKK:MEDEZE is ฿7.45 and 52 week low is ฿6.00.
When is next earnings date of Medeze Group PCL(BKK:MEDEZE)?
The next earnings date of Medeze Group PCL(BKK:MEDEZE) is .
Does Medeze Group PCL(BKK:MEDEZE) pay dividends? If so, how much?
The Dividend Yield %  of Medeze Group PCL(BKK:MEDEZE) is 2.54% (As of Today), Highest Dividend Payout Ratio of Medeze Group PCL(BKK:MEDEZE) was 1. The lowest was 0.21. And the median was 0.53. The  Forward Dividend Yield % of Medeze Group PCL(BKK:MEDEZE) is 3.81%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers